Coriell Life Sciences wins IBM's coveted "Entrepreneur of the Year" award at the global finals. Learn More ›
Coriell Life Sciences is a dynamic for-profit genomic storage and interpretation venture. Learn More ›
The CLS founders have published a significant paper in personalized medicine. Learn More ›
MIT Technology Review highlights Coriell Life Science’s GeneVault. Learn More ›
CLS provides genome-wide sequence storage and facilitates the doctor-patient exchange with interpretation and drug efficacy services. Learn More ›
Coriell Life Sciences offers a novel approach to genomic testing. Test once, store securely, and access expert interpretations when needed.
Taking advantage of the falling cost of genome sequencing, this new approach offers healthcare providers access to the world's leading experts in genomic interpretation, while delivering the concise clinical data they need for patient care.
Our core products – GeneVault, GeneExchange, and GeneDose – seamlessly integrate genomic medicine into clinical care while managing the breadth of information that is obtained through genomic sequencing.
The Coriell Life Sciences "ecosystem" allows healthcare providers, patients and payors to take advantage of the available sequencing technology while carving out and interpreting only that data needed for immediate use and securely storing the data in the GeneVault for future interpretation.
Find out more about the cutting edge research that created CLS happening at the Coriell Institute for Medical Research
In the News
Coriell Life Sciences recognized as filling a gap, needed for the implemention of genomic medicine.
March 4, 2014
February 24, 2014
February 21, 2014
February 12, 2014
February 11, 2014
February 10, 2014
February 7, 2014
February 7, 2014